AbbVie’s Atogepant shows breakthrough results for acute migraine relief
Suffering from acute migraine? You may soon bid adieu to the debilitating headache
Suffering from acute migraine? You may soon bid adieu to the debilitating headache
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
StarGuide GX delivers ultra-high sensitivity and high-resolution imaging, enabling fast, confident diagnostics
Amrutanjan is also rolling out its new campaign, 'Har Dard Mitaye'
The 7,000th store was inaugurated in Ayodhya, Uttar Pradesh
The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
GLP-1 therapies are among the fastest-growing drug classes worldwide, projected to drive a $95 billion obesity market by 2030
The clearance for TELLTALE positions Transmural Systems at the forefront of next-generation electrosurgical solutions for structural heart interventions
Subscribe To Our Newsletter & Stay Updated